{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:20:28Z","timestamp":1788967228441,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":2625,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1093\/annonc\/mds267","type":"journal-article","created":{"date-parts":[[2012,9,20]],"date-time":"2012-09-20T03:42:47Z","timestamp":1348112567000},"page":"vii120-vii123","source":"Crossref","is-referenced-by-count":135,"special_numbering":"S7","title":["Neuroendocrine bronchial and thymic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up"],"prefix":"10.1016","volume":"23","author":[{"given":"K.","family":"\u00d6berg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Hellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Ferolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Papotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1093\/annonc\/mds267_bb0010","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u2018carcinoid\u2019: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1093\/annonc\/mds267_bb0015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0169-5002(02)00080-6","article-title":"Pulmonary neuroendocrine tumors: incidence and prognosis of histological subtypes. A population-based study in Denmark","volume":"37","author":"Skuladottir","year":"2002","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1093\/annonc\/mds267_bb0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/cncr.23542","article-title":"Bronchopulmonary neuroendocrine tumors","volume":"113","author":"Gustafsson","year":"2008","journal-title":"Cancer"},{"issue":"6","key":"10.1093\/annonc\/mds267_bb0025","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/SLA.0b013e3181dd4ec4","article-title":"Thymic neuroendocrine tumors: a SEER database analysis of 160 patients","volume":"251","author":"Gaur","year":"2010","journal-title":"Ann Surg"},{"issue":"Suppl. 1","key":"10.1093\/annonc\/mds267_bb0030","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0959-8049(09)70040-1","article-title":"Lung tumors with neuroendocrine differentiation","volume":"45","author":"Travis","year":"2009","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1093\/annonc\/mds267_bb0035","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/00000478-199808000-00003","article-title":"Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid","volume":"22","author":"Travis","year":"1998","journal-title":"Am J Surg Pathol"},{"issue":"Suppl. 1","key":"10.1093\/annonc\/mds267_bb0040","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1007\/s00428-007-0445-0","article-title":"Neuro-endocrine tumors of the lung. A review of relevant pathological and molecular data","volume":"451","author":"Righi","year":"2007","journal-title":"Virchows Arch"},{"issue":"11","key":"10.1093\/annonc\/mds267_bb0045","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/JTO.0b013e31818b06e3","article-title":"The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer","volume":"3","author":"Travis","year":"2008","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1093\/annonc\/mds267_bb0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1530\/EJE-10-0950","article-title":"Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d'etude des Tumeurs Endocrines","volume":"165","author":"Goudet","year":"2011","journal-title":"Eur J Endocrinol\/Eur Feder Endocr Soc"},{"issue":"6","key":"10.1093\/annonc\/mds267_bb0055","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/MPA.0b013e3181ec1380","article-title":"NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the thorax (includes lung and thymus)","volume":"39","author":"Phan","year":"2010","journal-title":"Pancreas"},{"issue":"6","key":"10.1093\/annonc\/mds267_bb0060","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1365-2265.2003.01931.x","article-title":"Octreoscan in patients with bronchial carcinoid tumors","volume":"59","author":"Granberg","year":"2003","journal-title":"Clin Endocrinol"},{"issue":"4","key":"10.1093\/annonc\/mds267_bb0065","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2967\/jnumed.106.035667","article-title":"68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT","volume":"48","author":"Gabriel","year":"2007","journal-title":"J Nucl Med"},{"issue":"1 Suppl.","key":"10.1093\/annonc\/mds267_bb0070","doi-asserted-by":"crossref","first-page":"129S","DOI":"10.1378\/chest.123.1_suppl.129S","article-title":"Diagnosis of lung cancer: the guidelines","volume":"123","author":"Rivera","year":"2003","journal-title":"Chest"},{"issue":"10","key":"10.1093\/annonc\/mds267_bb0075","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/JTO.0b013e3181861d7b","article-title":"Proceedings of the IASLC International Workshop on Advances in Pulmonary Neuroendocrine Tumors 2007","volume":"3","author":"Lim","year":"2008","journal-title":"J Thorac Oncol"},{"issue":"4","key":"10.1093\/annonc\/mds267_bb0080","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ejcts.2004.05.052","article-title":"Surgical treatment of neuroendocrine tumors of the lung","volume":"26","author":"Daddi","year":"2004","journal-title":"Eur J Cardiothorac Surg"},{"issue":"4","key":"10.1093\/annonc\/mds267_bb0085","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jtcvs.2005.05.041","article-title":"The impact of stage and cell type on the prognosis of pulmonary neuroendocrine tumors","volume":"130","author":"Lim","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"Suppl. 2","key":"10.1093\/annonc\/mds267_bb0090","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1093\/annonc\/12.suppl_2.S111","article-title":"Chemotherapy and biotherapy in the treatment of neuroendocrine tumors","volume":"12","author":"Oberg","year":"2001","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1093\/annonc\/mds267_bb0095","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1158\/1078-0432.CCR-06-2053","article-title":"Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors","volume":"13","author":"Ekeblad","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1093\/annonc\/mds267_bb0100","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1200\/JCO.2010.30.2455","article-title":"Good clinical response to imatinib mesylate in atypical thymic carcinoid with KIT overexpression","volume":"29","author":"Hamada","year":"2011","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1093\/annonc\/mds267_bb0105","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00259-006-0355-4","article-title":"Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with foregut carcinoid tumors of bronchial, gastric and thymic origin","volume":"34","author":"van Essen","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1093\/annonc\/mds267_bb0110","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/14017439009098055","article-title":"Long-term follow-up of classical bronchial carcinoid tumors. Clinicopathologic observations","volume":"24","author":"Warren","year":"1990","journal-title":"Scand J Thorac Cardiovasc Surg"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419376689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419376689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/23\/suppl_7\/vii120\/6678716\/mds267.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T14:09:34Z","timestamp":1635775774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419376689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":21,"alternative-id":["S0923753419376689"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mds267","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}